You are currently on the new version of our website. Access the old version .
CancersCancers
  • Addendum
  • Open Access

26 February 2021

Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748

,
,
,
,
,
,
,
,
1
Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
2
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
3
Department of Obstetrics and Gynecology, Iwaki City Medical Center, Iwaki 973-8402, Japan
*
Authors to whom correspondence should be addressed.
The authors wish to make the following correction to this paper [1].
The authors would like to acknowledge Yuko Hashimoto and Shigeyuki Asano for providing cancer tissues. Therefore, the following sentence should be added in the “Acknowledgments” section:
“We are also grateful to Yuko Hashimoto and Shigeyuki Asano for providing cancer tissues.”
The authors would like to apologize for this omission from the original manuscript. The change does not affect the scientific results.

Reference

  1. Kojima, M.; Sugimoto, K.; Tanaka, M.; Endo, Y.; Kato, H.; Honda, T.; Furukawa, S.; Nishiyama, H.; Watanabe, T.; Soeda, S.; et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.